Bhutan vs Saudi Arabia: Treatment success rate for patients treated for MDR-TB
Bhutan
91.0%
in 2022
Saudi Arabia
93.0%
in 2022
Bhutan rank
21st
Saudi Arabia rank
20th
Treatment success rate for patients treated for MDR-TB over time
- Bhutan
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 91.0% in Bhutan, a difference of 2.0%.
The two have swapped places 3 times across 12 shared years of data; in 2007 it was Bhutan ahead.
Bhutan ranks 21st and Saudi Arabia ranks 20th of 163 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.5% | 38.0% | 35.5% | Bhutan |
| 2010s | 94.4% | 59.4% | 35.0% | Bhutan |
| 2020s | 93.0% | 81.0% | 12.0% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Bhutan or Saudi Arabia?
- Saudi Arabia, at 93.0% against 91.0% in Bhutan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Bhutan and Saudi Arabia?
- 2.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Bhutan and Saudi Arabia?
- 12 years are reported by both, from 2007 to 2022.
- How do Bhutan and Saudi Arabia rank globally for treatment success rate for patients treated for mdr-tb?
- Bhutan ranks 21st and Saudi Arabia ranks 20th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.